Western Blotting Processors Market

Introduction

Western blotting with the help of western blotting processors is an analytical technique used to separate and detect specific proteins from a complex protein sample. Proteins are separated by Western blotting processors based on molecular weight of proteins, which form bands on a gel and are then transferred onto a nitrocellulose or polyvinylidene fluoride membrane. The steps performed by western blotting processors are tissue preparation to antibody-based detection of proteins.

Western blotting processors find application in a wide variety of fields, where the large contribution is through the diagnostics market. The western blotting processors market is in the mature stage in developed countries, where use of automatic western blotting processors systems is more or less consistent to maintain the efficiency of the outcomes.

As the incidence of HIV is increasing across the globe, western blotting technique including western blotting processors are expected to gain popularity over the forecast period. Western blotting processors are time-consuming instruments for the detection of protein molecules.

One of the major reasons for the growing adoption of automated western blotting processors is the traditional ones requiring manpower for completion of protocol. The later western blotting processors technique demands continuous supervision, thus manpower is mandatory while performing this method manually to enhance reproducibility.

Automated western blotting processors perform steps such as mixing of solution, washing of gel, and hence reduce the time required for protocol by using multifunctional reagents. For research purposes in developing countries, traditional western blotting processors stiil widely used due to non-availability of resources and affordability issues.

In terms of revenue, the global western blotting processors  market is projected to grow at a CAGR of 5.1% during the forecast period and is expected to be valued at US$ 328.6 Mn by the end of 2028. The Asia-Pacific, China and Japan markets for western blotting processors are expected to witness siginificant growth in the global western blotting processors market over the forecast period.

The global western blotting processors  market is segmented into six major regions, namely North America, Latin America, Europe, Asia Pacific (Asia-Pacific excluding China and Japan), China, Japan and Middle East & Africa (MEA). In terms of value, North America is expected to be the dominant regional market for western blotting processors by 2018 end and is expected to expand at a CAGR of 5.2% over the forecast period in western blotting processors usage.

The Asia Pacific, China and Japan are expected to be the fast-growing regional markets for western blotting processors in terms of revenue in the global western blotting processors market, registering CAGRs of 5.7%, 6.8% and 6.1%, respectively, over the forecast period.

In North America, the U.S. is expected to be the dominant market for western blotting processors due to increasing incidence of HIV, BSE, FIV, and hepatitis B infections. According to the U.S. Department of Health & Human Services, 39,782 people received an HIV diagnosis in 2016. Availability of cost-effective, rapid diagnosis using western blotting processors is also a factor expected to drive the growth of the western blotting processors market in the U.S. over the forecast period.

The second dominant regional market for western blotting processors is Western Europe due to an increase in healthcare expenditure and funding by the government. In addition, there are several manufacturers present in the region, which address to an increasingly competitive market.

The favorable reimbursement policies by the government for disease diagnosis are also expected to drive the growth of the market for western blotting processors in the region. The growing research and development investments by companies to bring innovations in devices is also expected to fuel the growth of the western blotting processors.

The adoption of western blotting processors has increased in APCJ, which is expected to drive the growth of the market for western blotting processors in the region. According to the statistics provided by the WHO, the prevalence of HSV-2 has increased and is generally higher among women than among men in the Pacific, Southeast Asia and South Asia with 0.3 Mn, 33.2 Mn and 27.5 Mn, respectively. In addition, growing funding for agriculture research in India and ASEAN countries is also expected to drive the growth of the market for western blotting processors over the forecast period.